Medical Care Technologies (MDCE) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): N/A
• Price to Earnings (P/E): 5.6
• Beta (1Y): -0.54
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 1
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Shell Companies
• EPS (TTM): N/A
• Shares Outstanding: N/A
• 10 Day Avg. Volume: N/A
• 30 Day Avg. Volume: N/A
• PEG Ratio: 0.00
• Price to Book (P/B): 0.70
• Price to Sales (P/S): 1.21
• P/FCF Ratio: 8.36
• Enterprise Value/Market Cap: 10.00T>
• Enterprise Value/Revenue: 0.84
• Enterprise Value/Gross Profit: 1.58
• Enterprise Value/Ebitda: 3.42
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 61 Neutral
• Price Target: ―
• Action: N/A Date: 03/31/26
• Date: Action: N/A 03/31/26

The score is driven primarily by mixed financial performance: a strong rebound in profitability and a low-leverage balance sheet are offset by persistent revenue declines and inconsistent cash generation (notably the 2024 cash burn). Valuation is a supportive factor due to the low P/E, while technical strength cannot be assessed from the missing indicator data.

Positive Factors

Conservative Balance Sheet

The company's very low debt-to-equity and conservative balance sheet materially reduce default and financing risk, providing durable financial flexibility. Over 2–6 months this supports continued operations, opportunistic investment, and lowers probability of distress during revenue weakness.

Negative Factors

Persistent Revenue Decline

Sustained top-line decline over multiple years indicates structural demand weakness or loss of customer traction. Falling revenue undermines margin sustainability and makes earnings fragile, meaning profitability could reverse unless the company restores growth or diversifies revenue sources.

Medical Care Technologies Business Overview & Revenue Model

Company Description

Medical Care Technologies Inc., a development stage company, engages in opening and operating children's integrated health and wellness centers in China. The company sells and distributes pharmaceutical and nutraceutical products, and other mercha...

Read more

Medical Care Technologies Inc., a development stage company, engages in opening and operating children's integrated health and wellness centers in China. The company sells and distributes pharmaceutical and nutraceutical products, and other mercha...

How the Company Makes Money

null...

Medical Care Technologies Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	1.07M	656.40K	731.97K	3.47M
Gross Profit	576.12K	321.85K	-57.24K	1.33M
EBITDA	238.06K	152.99K	0.00	1.33M
Net Income	230.77K	150.38K	-387.51K	1.10M
Balance Sheet
Total Assets	1.89M	1.47M	603.46K	1.05M
Cash, Cash Equivalents and Short-Term Investments	490.55K	52.34K	35.39K	11.80K
Total Debt	10.00K	67.67K	39.14K	27.94K
Total Liabilities	26.68K	82.03K	69.48K	124.01K
Stockholders Equity	1.86M	1.38M	533.98K	921.49K
Cash Flow
Free Cash Flow	155.47K	-616.08K	29.91K	139.55K
Operating Cash Flow	155.47K	-616.08K	29.91K	139.55K
Investing Cash Flow	0.00	0.00	0.00	0.00
Financing Cash Flow	70.13K	633.03K	-6.32K	-127.75K

Medical Care Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
MDCE	61 Neutral	―	5.63	15.97%	―	―	―
MRM	58 Neutral	$8.85M	-0.60	48.22%	―	13.71%	―
NAAS	46 Neutral	$2.16M	0.73	―	―	-13.78%	38.67%
NVVE	44 Neutral	$2.75M	-0.03	-3734.39%	―	-9.58%	86.27%
VMAR	42 Neutral	$2.03M	-0.31	―	―	-66.16%	78.81%